madman
Super Moderator
Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double‑Blind, Controlled Study
Key Points
The efficacy of oral finasteride in female pattern hair loss (FPHL) has been reported. Topical formulations of finasteride have been developed in an attempt to minimize systemic adverse effects.
Our study revealed the efficacy of topical finasteride/ minoxidil in the treatment of FPHL; the combination treatment also increased hair diameter over topical minoxidil alone.
Topical finasteride/minoxidil may be a promising treatment option in FPHL. However, given the possibility of systemic absorption, it should be reserved for postmenopausal women with no personal or family history of breast cancer.
5 Conclusion
FMX may be considered a promising option for the treatment of FPHL as it had an additional benefit over MX as monotherapy in terms of increasing hair diameter. However, the possibility of systemic absorption means it should be reserved for postmenopausal women with no personal or family history of breast cancer.
Key Points
The efficacy of oral finasteride in female pattern hair loss (FPHL) has been reported. Topical formulations of finasteride have been developed in an attempt to minimize systemic adverse effects.
Our study revealed the efficacy of topical finasteride/ minoxidil in the treatment of FPHL; the combination treatment also increased hair diameter over topical minoxidil alone.
Topical finasteride/minoxidil may be a promising treatment option in FPHL. However, given the possibility of systemic absorption, it should be reserved for postmenopausal women with no personal or family history of breast cancer.
5 Conclusion
FMX may be considered a promising option for the treatment of FPHL as it had an additional benefit over MX as monotherapy in terms of increasing hair diameter. However, the possibility of systemic absorption means it should be reserved for postmenopausal women with no personal or family history of breast cancer.
